This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Boceprevir a valuable addition for hepatitis C. Pharmacoecon. Outcomes News 643, 5 (2011). https://doi.org/10.2165/00151234-201106430-00014
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201106430-00014